This study tests if injecting a medicine called ANX007 into the eye can help people with a condition called Geographic Atrophy (GA), which is a part of a disease that affects the eye and is known as age-related macular degeneration (AMD). GA leads to vision loss, and researchers want to see if these injections can slow down that loss. To join, participants must have GA caused by AMD, and their condition will be checked by a doctor and a special reading center. People cannot join if their GA is due to other reasons like Stargardt disease or certain eye problems.

• Duration: Participants will receive injections every month.
• Visits: Regular visits for injections and check-ups are necessary.
• Eligibility: Only those with GA due to AMD can participate.